April 8 10:03 EDT "...spoke to an expert oncologist who is an investigator in the current Provenge study. ..."
10:13 EDT "...spoke with an expert oncologist yesterday that said he is not convinced on Dendreon's Provenge efficacy and does not expect the drug to demonstrate a survival benefit. ..."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.